A third party may hold intellectual property, including patent rights that are important or necessary to the development of our product candidates or use of our technology platforms.
Certain patents held by third parties cover Fc engineering methods and mutations in Fc regions to enhance the binding of Fc regions to Fc receptors on immune cells.